For research teamsHelp me find a study
Back to all studies
CompletedNCT05870540

Intranasal BPL-003, With Open Label Extension, for treatment-resistant depression

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing Intranasal BPL-003, With Open Label Extension, for treatment-resistant depression.

DepressionDrugFrom 18 Years to 75 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether BPL-003 may be useful for adults experiencing depression.

What would participation involve?

Participants may receive BPL-003, attend study visits with the research team. The registry lists locations in Australia, in Germany, and in Poland.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: September 14, 2023
Recruitment status
Completed
Enrollment listed in the registry
196
Sponsor
Beckley Psytech Limited
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Australia, United Kingdom, ...
Age range
From 18 Years to 75 Years
Official registry ID
NCT05870540
Official title
A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, With Open Label Extension, in Patients With Treatment-Resistant Depression

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT05870540. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Australia · 4 sites
  • Royal Prince Alfred Hospital
    Sydney, New South Wales
    Site status: Not listed — confirm with the team
  • Dept. of Psychiatry and School Psychological Sciences, Monash University
    Clayton, Victoria
    Site status: Not listed — confirm with the team
  • NeuroCentrix Research
    Melbourne
    Site status: Not listed — confirm with the team
  • Royal Melbourne Hospital, University of Melbourne
    Parkville
    Site status: Not listed — confirm with the team
Germany · 5 sites
  • Charité - Universitätsmedizin Berlin
    Berlin
    Site status: Not listed — confirm with the team
  • OVID Clinic, Augmented Psychotherapy
    Berlin
    Site status: Not listed — confirm with the team
  • Department of Psychiatry, University Hospital Frankfurt
    Frankfurt am Main
    Site status: Not listed — confirm with the team
  • Central Institute of Mental Health, Dept. of Molecular Neuroimaging
    Mannheim
    Site status: Not listed — confirm with the team
  • Universitätsklinik für Psychiatrie und Psychotherapie, Calwerstr. 14
    Tübingen
    Site status: Not listed — confirm with the team
Poland · 5 sites
  • Department of Psychiatry, UCK
    Gdansk
    Site status: Not listed — confirm with the team
  • Centrum Badań Klinicznych PI-House sp. z o.o.
    Gdansk
    Site status: Not listed — confirm with the team
  • SPZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
    Lodz
    Site status: Not listed — confirm with the team
  • Klinika Inventiva
    Tuszyn
    Site status: Not listed — confirm with the team
  • Department of Pharmacology and Physiology of CNS
    Warsaw
    Site status: Not listed — confirm with the team
Spain · 6 sites
  • Hospital del Mar
    Barcelona
    Site status: Not listed — confirm with the team
  • Parc Sanitari Sant Joan de Deu HD Numancia
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Clinic de Barcelona, Psychiatry and Psychology Dept.
    Barcelona
    Site status: Not listed — confirm with the team
  • Fundación de Investigación HM Hospital
    Madrid
    Site status: Not listed — confirm with the team
  • Centro de Salud Mental La Corredoria
    Oviedo
    Site status: Not listed — confirm with the team
  • Centro Salud San Juan
    Salamanca
    Site status: Not listed — confirm with the team
United Kingdom · 3 sites
  • NIHR Exeter Clinical Research Facility
    Exeter
    Site status: Not listed — confirm with the team
  • King's College London - Institute of Psychiatry, Psychology & Neuroscience (IoPPN) - Centre for Affective Disorders (CfAD)
    London
    Site status: Not listed — confirm with the team
  • Clerkenwell Health
    London
    Site status: Not listed — confirm with the team
United States · 19 sites
  • UAB School of Public Health, Department of Health Behavior
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Woodland Research Northwest
    Rogers, Arkansas
    Site status: Not listed — confirm with the team
  • Kadima Neuropsychiatry Institute
    San Diego, California
    Site status: Not listed — confirm with the team
  • San Francisco Insight and Integration Center
    San Francisco, California
    Site status: Not listed — confirm with the team
  • Pacific Neuroscience Institute, Treatment and Research in Psychedelics (TRIP) Program
    Santa Monica, California
    Site status: Not listed — confirm with the team
  • Wholeness Center
    Fort Collins, Colorado
    Site status: Not listed — confirm with the team
  • Segal Trials Center for Psychedelic and Cannabis Research
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Emory University, Brain Health Center, Department of Psychiatry and Behavioral Sciences
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • CenExel ACMR
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • CenExel iResearch
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Sunstone Medical PC (Sunstone Therapies / Aquilino Cancer Center)
    Rockville, Maryland
    Site status: Not listed — confirm with the team
  • Boston Clinical Trials
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • CenExel HRI
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • New York State Psychiatric Institute
    New York, New York
    Site status: Not listed — confirm with the team
  • Portland Psychotherapy
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Insite clinical research
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • AIM Trials
    Plano, Texas
    Site status: Not listed — confirm with the team
  • Cedar Clinical Research
    Draper, Utah
    Site status: Not listed — confirm with the team
  • University of Wisconsin, Dept of Family Medicine & Community Health
    Madison, Wisconsin
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving BPL-003. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 75 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Beckley Psytech Limited, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.